Literature DB >> 25154523

Perioperative changes of procalcitonin levels in patients undergoing liver transplantation.

T Kaido1, K Ogawa, Y Fujimoto, A Mori, E Hatano, H Okajima, S Uemoto.   

Abstract

BACKGROUND: Severe sepsis is a life-threatening complication after liver transplantation (LT) that can be difficult to diagnose and appropriately treat after LT because of patients being treated with immunosuppressants. The present study examines perioperative changes in serum procalcitonin (PCT), a specific marker of systemic bacterial infection, and determines the value of PCT as a diagnostic tool for bacteremia or rejection.
METHODS: Perioperative serum PCT levels were prospectively assessed in 104 consecutive adult patients undergoing LT (living-donor LT, n = 90; deceased-donor LT, n = 14) between May 2010 and August 2012.
RESULTS: Serum PCT levels remarkably increased soon after LT and gradually decreased thereafter, but were not increased in patients diagnosed with cytomegalovirus infection or acute cellular rejection. Serum PCT levels in patients who underwent deceased-donor LT were significantly higher than in those who underwent living-donor LT until postoperative day (POD) 7. Serum PCT levels were significantly higher in patients with bacteremia than in those without bacteremia after POD 14. In patients with post-transplant bacteremia, PCT levels increased again after POD 7 in patients who died within 3 months of LT, while levels remained low after POD 7 in patients who were alive. A positive predictive value of 83.3% for bacteremia and a negative predictive value of 97.4% were obtained at PCT cutoffs of 2.0 and 0.5 ng/mL, respectively.
CONCLUSION: Serum PCT measurement, using appropriate cutoff values, could help diagnose severe infection, and might be able to differentiate bacteremia from acute cellular rejection.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bacteremia; liver transplantation; procalcitonin

Mesh:

Substances:

Year:  2014        PMID: 25154523     DOI: 10.1111/tid.12282

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  7 in total

1.  The impact of tracheotomy on levels of procalcitonin in patients without sepsis: a prospective study.

Authors:  Xingui Dai; Chunlai Fu; Changfa Wang; Yeping Cai; Sheng'an Zhang; Wei Guo; Daibing Kuang
Journal:  Clinics (Sao Paulo)       Date:  2015-09       Impact factor: 2.365

Review 2.  Procalcitonin-guided diagnosis and antibiotic stewardship revisited.

Authors:  Ramon Sager; Alexander Kutz; Beat Mueller; Philipp Schuetz
Journal:  BMC Med       Date:  2017-01-24       Impact factor: 8.775

3.  Procalcitonin for infections in the first week after pediatric liver transplantation.

Authors:  Vladimir L Cousin; Kalinka Lambert; Shahar Trabelsi; Annick Galetto-Lacour; Klara M Posfay-Barbe; Barbara E Wildhaber; Valérie A McLin
Journal:  BMC Infect Dis       Date:  2017-02-15       Impact factor: 3.090

4.  Applicability of common inflammatory markers in diagnosing infections in early period after liver transplantation in intensive care setting.

Authors:  Wojciech Figiel; Michał Grąt; Grzegorz Niewiński; Waldemar Patkowski; Krzysztof Zieniewicz
Journal:  Sci Rep       Date:  2020-03-03       Impact factor: 4.379

5.  Pneumonia in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.

Authors:  Daniel E Dulek; Nicolas J Mueller
Journal:  Clin Transplant       Date:  2019-04-23       Impact factor: 2.863

6.  Bacterial and Fungal Infections After Liver Transplantation: Microbial Epidemiology, Risk Factors for Infection and Death with Infection.

Authors:  Weili Zhang; Wentao Wang; Mei Kang; Siying Wu; Ya Liu; Quanfeng Liao; Yuling Xiao; Ying Ma; Yi Xie
Journal:  Ann Transplant       Date:  2020-05-19       Impact factor: 1.530

7.  Procalcitonin in early allograft dysfunction after orthotopic liver transplantation: a retrospective single centre study.

Authors:  Katja Frick; Elisabeth A Beller; Marit Kalisvaart; Philipp Dutkowski; Reto A Schüpbach; Stephanie Klinzing
Journal:  BMC Gastroenterol       Date:  2022-08-31       Impact factor: 2.847

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.